Rafael J. Zenteno-Hernandez

Mexico City, DIF, Mexico

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Long-term angiogenic and thromboinflammatory signatures in post-COVID-19 syndrome.

Long-term angiogenic and thromboinflammatory signatures in post-COVID-19 syndrome.

Journal: Angiogenesis

Published: May 08, 2026

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

EWAS in COPD by biomass-burning smoke exposure identifies low levels of endothelin-1 by hypermethylation of EDN1.

Journal: Epigenomics

Published: July 23, 2025

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Efficacy of Indacaterol vs Tiotropium in COPD patients due to biomass exposure in improving quality of life and reducing symptoms.

Journal: Respiratory medicine

Published: January 22, 2025

Variants rs3804099 and rs3804100 in the TLR2 Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2.

Variants rs3804099 and rs3804100 in the TLR2 Gene Induce Different Profiles of TLR-2 Expression and Cytokines in Response to Spike of SARS-CoV-2.

Journal: International journal of molecular sciences

Published: September 27, 2024

Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.

Shorter telomere length in COPD cases secondary to biomass-burning smoke exposure.

Journal: Respiratory research

Published: September 17, 2024

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Fractional Exhaled Nitric Oxide (FeNO) in Biomass Smoke-Associated Chronic Obstructive Pulmonary Disease.

Journal: Medical sciences (Basel, Switzerland)

Published: August 21, 2024

Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude.

Validation of new predictors of mortality and BODE index variants in patients with COPD at moderate altitude.

Journal: ERJ open research

Published: April 05, 2024

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Effectiveness of ICS/LABA and LAMA/LABA in COPD due to biomass.

Journal: ERJ open research

Published: February 16, 2024

Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function.

Dynapenia and Sarcopenia in Post-COVID-19 Syndrome Hospitalized Patients Are Associated with Severe Reduction in Pulmonary Function.

Journal: Journal of clinical medicine

Published: August 11, 2023

Clinical and cardiovascular characteristics from subjects with in COVID-19 and viral outbreaks.

Clinical and cardiovascular characteristics from subjects with in COVID-19 and viral outbreaks.

Journal: Canadian journal of respiratory therapy : CJRT = Revue canadienne de la therapie respiratoire : RCTR

Published: April 06, 2022

Prevalence, attitude, knowledge, and risk perception towards COVID-19 in COPD patients associated to biomass exposure.

Prevalence, attitude, knowledge, and risk perception towards COVID-19 in COPD patients associated to biomass exposure.

Journal: International journal of environmental health research

Published: December 30, 2021

Evaluating of Red Blood Cell Distribution Width, Comorbidities and Electrocardiographic Ratios as Predictors of Prognosis in Patients with Pulmonary Hypertension.

Evaluating of Red Blood Cell Distribution Width, Comorbidities and Electrocardiographic Ratios as Predictors of Prognosis in Patients with Pulmonary Hypertension.

Journal: Diagnostics (Basel, Switzerland)

Published: June 15, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026